You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EVEREST II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs in Polypoidal Choroidal Vasculopathy (PCV)

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • Indocyanine Green Angiography
  • Singapore, Singapore
  • +2 more
Sep 27, 2021

Mitral Valve Insufficiency, Mitral Valve Regurgitation, Mitral Valve Incompetence Trial in Evanston, Indianapolis (Percutaneous

Completed
Has Results
  • Mitral Valve Insufficiency
  • +4 more
  • Percutaneous mitral valve repair using MitraClip implant
  • Evanston, Illinois
  • +1 more
Nov 5, 2018

Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
  • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
  • Singapore, Singapore
  • +2 more
Nov 14, 2022

Acute Heart Failure, Diuretic Resistance Trial (Furosemide, Metolazone, Acetazolamide)

Not yet recruiting
  • Acute Heart Failure
  • Diuretic Resistance
  • (no location specified)
Aug 8, 2023

Cardiac Arrhythmias at Extreme Altitude

Recruiting
  • Arrhythmias, Cardiac
  • +3 more
  • Ambulatory rhythm recording
  • Kathmandu, Nepal
    National Academy of Medical Sciences, Bir Hospital
Jan 13, 2023

EVEREST-HN 1: EVolution ofpatiEnt-REported Symptom-based Risk

Recruiting
  • Head and Neck Cancer
  • No intervention.
  • Leeds, United Kingdom
  • +3 more
Jun 14, 2023

Solid Tumor Trial in Beijing (Sacituzumab Govitecan-hziy)

Recruiting
  • Solid Tumor
  • Sacituzumab Govitecan-hziy
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 3, 2021

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

Hypoxia Trial in Ankara (Normobaric Hypoxia Exposure, Normobaric Normoxia Exposure)

Completed
  • Hypoxia
  • Normobaric Hypoxia Exposure
  • Normobaric Normoxia Exposure
  • Ankara, Turkey
    Ankara University
Jul 22, 2023

Percutaneous Mitral Valve Intervention: Predicting Improvements

Completed
  • Mitral Regurgitation
  • Mitral Valve Insufficiency
    • London, United Kingdom
      Guy's and St Thomas' NHS Foundation Trust
    Jul 28, 2021

    Pregnant, High Altitude Trial (cesarian surgery)

    Not yet recruiting
    • Pregnant
    • High Altitude
    • cesarian surgery
    • (no location specified)
    Jan 27, 2023

    Heart Failure, Edema, Volume Overload Trial in Istanbul, Kocaeli (Diuretic therapy)

    Recruiting
    • Heart Failure
    • +3 more
    • Diuretic therapy
    • Istanbul, Turkey
    • +4 more
    Jan 21, 2023

    Tricuspid Regurgitation Trial in Belgium, France (Tricuspid valve, Best medical treatment)

    Recruiting
    • Tricuspid Regurgitation
    • Tricuspid valve
    • Best medical treatment
    • Brugge, Belgium
    • +23 more
    Apr 29, 2022

    Colorectal Cancer Trial in Worldwide (Dose escalation of cetuximab, Standard first line treatment with cetuximab + Folfiri)

    Completed
    Has Results
    • Colorectal Cancer
    • Dose escalation of cetuximab
    • Standard first line treatment with cetuximab + Folfiri
    • Innsbruck, Austria
    • +29 more
    Oct 10, 2019

    Phantom Limb Pain Trial (device, behavioral, other)

    Not yet recruiting
    • Phantom Limb Pain
    • M1 anodal home-based tDCS
    • +2 more
    • (no location specified)
    Jun 14, 2022

    Acute Heart Failure Trial in Malang, Yogyakarta (Adrecizumab)

    Recruiting
    • Acute Heart Failure
    • Malang, Indonesia
    • +1 more
    Mar 8, 2021

    Fusion Rate Using K2M VESUVIUS® Demineralized Fibers With K2M

    Terminated
    Has Results
    • Spinal Stenosis
    • +2 more
      • (no location specified)
      Feb 9, 2021

      Covid19, SARS-CoV2 Infection, Hypoxia, Altitude Trial in Chamonix-Mont-Blanc (COVID19)

      Recruiting
      • Covid19
      • +2 more
      • COVID19
      • Chamonix-Mont-Blanc, Auvergne-Rhône-Alpes, France
        Institut de Formation et de Recherche en Médecine de Montagne (I
      Dec 21, 2021

      Locally Advanced or Metastatic Unresectable Urothelial Cancer Trial in Worldwide (Sacituzumab Govitecan-hziy, Paclitaxel,

      Recruiting
      • Locally Advanced or Metastatic Unresectable Urothelial Cancer
      • Sacituzumab Govitecan-hziy
      • +3 more
      • Phoenix, Arizona
      • +210 more
      Jul 28, 2022

      Heart Failure, Diabetes, Type 2 Trial in United States (Dapagliflozin 10 MG, Protocolized Diuretic Therapy)

      Recruiting
      • Heart Failure
      • Diabetes Mellitus, Type 2
      • Dapagliflozin 10 MG
      • Protocolized Diuretic Therapy
      • Jackson, Mississippi
      • +5 more
      Feb 1, 2022

      Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)

      Recruiting
      • Intracranial Hemorrhages
      • Atrial Fibrillation
      • Elk Grove Village, Illinois
      • +152 more
      Jan 23, 2023

      Asphyxia Neonatorum, Birth Asphyxia Trial in Edmonton (Heart rate assessment using the Neonatal Resuscitation Program 6-sec

      Withdrawn
      • Asphyxia Neonatorum
      • Birth Asphyxia
      • Heart rate assessment using the Neonatal Resuscitation Program 6-sec assessment method
      • Heart rate assessment using Tap-based smartphone application
      • Edmonton, Alberta, Canada
        Royal Alexandra Hospital
      Sep 3, 2021

      Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase

      Not yet recruiting
      • Refractory Cancer
      • +3 more
      • IMA402 (Phase Ia)
      • +2 more
      • Heidelberg, Baden-Wuerttemberg, Germany
      • +12 more
      Jul 14, 2023

      AUD Trial in Changsha (Naltrexone implant, Placebo)

      Recruiting
      • AUD
      • Naltrexone implant
      • Placebo
      • Changsha, 湖南省, China
        Hunan Second People's Hospital
      Jun 23, 2023

      SOFA and APACHE II Scoring Systems for Predicting Outcome of

      Completed
      • Neurologic Disorder
        • Lalitpur, Nepal
          Sumit Shahi
        Oct 31, 2023